STATIN GENERICS: EFFICACY AND SAFETY RATIO

V. P. Voronina; A. A. Serazhim; A. V. Zagrebelnyi; S. Yu. Martsevich; S. A. Shalnova

doi:10.20996/1819-6446-2009-5-6-59-62

Рациональная фармакотерапия в кардиологии (Jan 2016)

STATIN GENERICS: EFFICACY AND SAFETY RATIO

V. P. Voronina,
A. A. Serazhim,
A. V. Zagrebelnyi,
S. Yu. Martsevich,
S. A. Shalnova

Affiliations

V. P. Voronina: State Research Center for Preventive Medicine of Rosmedtechnology
A. A. Serazhim: State Research Center for Preventive Medicine of Rosmedtechnology
A. V. Zagrebelnyi: State Research Center for Preventive Medicine of Rosmedtechnology
S. Yu. Martsevich: State Research Center for Preventive Medicine of Rosmedtechnology
S. A. Shalnova: State Research Center for Preventive Medicine of Rosmedtechnology

DOI: https://doi.org/10.20996/1819-6446-2009-5-6-59-62
Journal volume & issue: Vol. 5, no. 6
pp. 59 – 62

Abstract

Read online

Statin usage for primary and secondary prevention of cardiovascular diseases is focused. Rational choice between original and generic drugs is discussed taking into account efficacy and safety ratio.

Published in Рациональная фармакотерапия в кардиологии

ISSN: 1819-6446 (Print); 2225-3653 (Online)
Publisher: Столичная издательская компания
Country of publisher: Russian Federation
LCC subjects: Medicine: Therapeutics. Pharmacology; Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website: https://www.rpcardio.online/jour

About the journal

Abstract

Keywords